The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Cigarette smoking and the progression of multiple sclerosis
Abstract
An increased risk of multiple sclerosis among smokers has been found in several prospective epidemiological studies. The association between smoking and progression of multiple sclerosis has not been examined. We identified patients who had a first multiple sclerosis diagnosis recorded in the General Practice Research Database (GPRD) between January 1993 and December 2000. Their diagnosis and date of first symptoms were confirmed through examination of medical records. Smoking status was obtained from the computer records. To assess the association between smoking and risk of multiple sclerosis, we conducted a case-control study nested in the GPRD. Up to 10 controls per case were randomly selected, matched on age, sex, practice, date of joining the practice and availability of smoking data. To assess the association between smoking and progression of multiple sclerosis, we conducted a cohort study of multiple sclerosis cases with a relapsing-remitting onset. Our nested case-control study included 201 cases of multiple sclerosis and 1913 controls. The odds ratio [95% confidence interval (CI)] of multiple sclerosis was 1.3 (1.0-1.7) for ever smokers compared with never smokers. Our cohort study included 179 cases with a mean (median) length of follow-up of 5.3 (5.3) years. The hazard ratio of secondary progression was 3.6 (95% CI 1.3-9.9) for ever smokers compared with never smokers. These results support the hypothesis that cigarette smoking is associated with an increased risk of multiple sclerosis, and suggest that smoking may be a risk factor for transforming a relapsing-remitting clinical course into a secondary progressive course.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839
Self-citationDemyelination: The Role of Reactive Oxygen and Nitrogen Species
Smith, K. J., Kapoor, R., & Felts, P. A. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00212.x · Cited by 600
Validity of the General Practice Research Database
Jick, S. S., Kaye, J. A., Vasilakis‐Scaramozza, C., Rodríguez, L. A. G., Ruigómez, A., Meier, C. R., Schlienger, R. G., Black, C., & Jick, H. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.5.686.32205 · Cited by 584
Self-citationUse of the UK General Practice Research Database for pharmacoepidemiology
García Rodríguez, L. A., & Pérez Gutthann, S. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00701.x · Cited by 558
A Long-term follow-up study of women using different methods of contraception— an interim report
Vessey, M., Doll, S. R., Peto, R., Johnson, B., & Wiggins, P. (1976) · Journal of Biosocial Science · doi:10.1017/s0021932000010890 · Cited by 401
Redford, E. (1997) · Brain · doi:10.1093/brain/120.12.2149 · Cited by 326
Electrically active axons degenerate when exposed to nitric oxide
Smith, K. J., Kapoor, R., Hall, S. M., & Davies, M. (2001) · Annals of Neurology · doi:10.1002/ana.96 · Cited by 320
Cigarette Smoking and Incidence of Multiple Sclerosis
Hernan, M. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.1.69 · Cited by 292
Migrant studies in multiple sclerosis
Gale, C. R., & Martyn, C. N. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(95)80008-v · Cited by 289
Pathogenesis of tissue injury in MS lesions
Trapp, B. D., Bö, L., Mörk, S., & Chang, A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00081-8 · Cited by 259
Blockers of sodium and calcium entry protect axons from nitric oxide‐mediated degeneration
Kapoor, R., Davies, M., Blaker, P. A., Hall, S. M., & Smith, K. J. (2003) · Annals of Neurology · doi:10.1002/ana.10443 · Cited by 252
The epidemiology of multiple sclerosis: A general overview
Poser, C. M. (1994) · Annals of Neurology · doi:10.1002/ana.410360805 · Cited by 225
Wallin, M. T., Page, W. F., & Kurtzke, J. F. (2004) · Annals of Neurology · doi:10.1002/ana.10788 · Cited by 224
Geographic variation of MS incidence in two prospective studies of US women
Hernán, M. A., Olek, M. J., & Ascherio, A. (1999) · Neurology · doi:10.1212/wnl.53.8.1711 · Cited by 219
Self-citationNitromation of amines by stimulated macrophages
Miwa, M., Stuehr, D. J., Marletta, M. A., Wishnok, J. S., & Tannenbaum, S. R. (1987) · Carcinogenesis · doi:10.1093/carcin/8.7.955 · Cited by 208
Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes
Mitrovic, B., Ignarro, L. J., Vinters, H. V., Akers, M.-A., Schmid, I., Uittenbogaart, C., & Merrill, J. E. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00491-m · Cited by 193
Oral contraceptives and reproductive factors in multiple sclerosis incidence
Villard-Mackintosh, L., & Vessey, M. P. (1993) · Contraception · doi:10.1016/0010-7824(93)90088-o · Cited by 172
The influence of oral contraceptives on the risk of multiple sclerosis
Thorogood, M., & Hannaford, P. C. (1998) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb10008.x · Cited by 159
CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis
Rejdak, K., Eikelenboom, M. J., Petzold, A., Thompson, E. J., Stelmasiak, Z., Lazeron, R. H. C., Barkhof, F., Polman, C. H., Uitdehaag, B. M. J., & Giovannoni, G. (2004) · Neurology · doi:10.1212/01.wnl.0000142043.32578.5d · Cited by 129
Fan, T.-Y., & Tannenbaum, S. R. (1973) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf60186a006 · Cited by 112
Zhou, J., Yan, X., Guo, F., Sun, N. Y., Qian, Z. J., & Ding, D. Y. (2000) · PubMed · Cited by 106
Axon loss in multiple sclerosis
Scolding, N. J., & Franklin, R. J. M. (1998) · The Lancet · doi:10.1016/s0140-6736(05)60463-1 · Cited by 76
Node, K., Kitakaze, M., Yoshikawa, H., Kosaka, H., & Hori, M. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00189-6 · Cited by 71
Modulation of Nitric-Oxide Synthase by Nicotine
Tonnessen, B. H., Severson, S. R., Hurt, R. D., & Miller, V. M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38944-x · Cited by 67
Ohshima, H., Béréziat, J., & Bartsch, H. (1982) · Carcinogenesis · doi:10.1093/carcin/3.1.115 · Cited by 67
Blocking the endogenous formation of N-nitroso compounds and related carcinogens.
Bartsch, H., & Frank, N. (1996) · PubMed · Cited by 56
Rapid formation of carcinogenic N-nitrosamines in aqueous alkaline solutions
Challis, B. C., & Kyrtopoulos, S. Α. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.106 · Cited by 55
Glial cell-specific differences in response to alkylation damage
LeDoux, S. P., Shen, C.-C., Grishko, V. I., Fields, P. A., Gard, A. L., & Wilson, G. L. (1998) · Glia · doi:10.1002/(sici)1098-1136(199811)24:3<304::aid-glia4>3.0.co;2-1 · Cited by 46
Effect of Cigarette Smoke on Endothelial Regenerationin Vivoand Nitric Oxide Levels
Sarkar, R., Gelabert, H. A., Mohiuddin, K. R., Thakor, D. K., & Santibanez-Gallerani, A. S. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1998.5502 · Cited by 45
Nitric oxide and the axonal death cascade
Waxman, S. G. (2003) · Annals of Neurology · doi:10.1002/ana.10397 · Cited by 43
Nicotine-evoked nitric oxide release in the rat hippocampal slice
Smith, D. A., Hoffman, A. F., David, D., Adams, C. E., & Gerhardt, G. A. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00725-3 · Cited by 37
Plasma Nitric Oxide Before and After Smoking Cessation with Nicotine Nasal Spray
Miller, V. M., Lewis, D. A., Rud, K. S., Offord, K. P., Croghan, I. T., & Hurt, R. D. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04371.x · Cited by 30
Effects of ascorbic acid and thiocyanate on nitrosation of proline in the dog stomach
Licht, W. R., James, G. F., & Deen, W. M. (1988) · Carcinogenesis · doi:10.1093/carcin/9.3.373 · Cited by 23
Characterization of the Cytotoxic Activity of Nitric Oxide Generating N-Nitroso Compounds.
TANNO, M., SUEYOSHI, S., Miyata, N., & Umehara, K. (1997) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.45.595 · Cited by 15
Suemaru, K., Kawasaki, H., Gomita, Y., & Tanizaki, Y. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01204-1 · Cited by 14
Kordower (1999) · doi:10.1002/1531-8249(199909)46:3
Cited by
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Olsson, T., Barcellos, L. F., & Alfredsson, L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.187 · Cited by 1,185
Gender differences in autoimmune disease
Ngo, S. T., Steyn, F. J., & McCombe, P. A. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.04.004 · Cited by 1,074
Effects of tobacco smoke on immunity, inflammation and autoimmunity
Arnson, Y., Shoenfeld, Y., & Amital, H. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.12.003 · Cited by 967
Primary-progressive multiple sclerosis
Miller, D. H., & Leary, S. M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70243-0 · Cited by 818
Metadata
- Authors
- Hernán, M. A., Jick, S. S., Logroscino, G., Olek, M. J., Ascherio, A., & Jick, H.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-03-09
- Volume
- 128
- Issue
- 6
- Pages
- 1461-1465
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2127502418
- Cited by
- 294
- References
- 38
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.